Immunocore Holdings plc Depreciation in USD from 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immunocore Holdings plc quarterly/annual Depreciation history and growth rate from 2021 to Q1 2025.
  • Immunocore Holdings plc Depreciation for the quarter ending March 31, 2025 was $854K, a 15.5% decline year-over-year.
  • Immunocore Holdings plc annual Depreciation for 2024 was $4.2M, a 2.79% increase from 2023.
  • Immunocore Holdings plc annual Depreciation for 2023 was $4.09M, a 23.3% decline from 2022.
  • Immunocore Holdings plc annual Depreciation for 2022 was $5.34M, a 29.7% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Immunocore Holdings plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $854K -$157K -15.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $1.01M +$59K +6.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $952K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08

Immunocore Holdings plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.2M +$114K +2.79% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 $4.09M -$1.25M -23.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $5.34M -$2.26M -29.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $7.59M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.